Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine

Eur J Paediatr Neurol. 2022 Jul 31;40:40-43. doi: 10.1016/j.ejpn.2022.07.007. Online ahead of print.ABSTRACTPediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.PMID:35933829 | DOI:10.1016/j.ejpn.2022.07.007

Source: European Journal of Paediatric Neurology - August 7, 2022 Category: Neurology Authors: Dekel Avital Shlomi Peretz Eliauh Perlow Osnat Konen Edna Inbar Yarden Bulkowstein Elhanan Nahum Sharon Aharoni Lital Cohen Vig Yoram Nevo Eitan Auriel Rachel Straussberg Source Type: research